SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-014776
Filing Date
2022-06-10
Accepted
2022-06-10 16:05:27
Documents
13
Period of Report
2022-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20220610_8k.htm   iXBRL 8-K 38285
  Complete submission text file 0001437749-22-014776.txt   186412

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bcda-20220610.xsd EX-101.SCH 4035
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20220610_def.xml EX-101.DEF 13506
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20220610_lab.xml EX-101.LAB 17660
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20220610_pre.xml EX-101.PRE 13473
7 EXTRACTED XBRL INSTANCE DOCUMENT bcda20220610_8k_htm.xml XML 4253
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 221008851
SIC: 2836 Biological Products, (No Diagnostic Substances)